Orthocell gives mobility back to quadriplegic patients
Orthocell's (ASX: OCC) regenerative device, CelGro, is helping give mobility back to quadriplegic patients.
News
Orthocell
Webcast
Orthocell Limited Investor Briefing – 23 September
Orthocell Limited (ASX: OCC) is a world-leading regenerative medicine company providing innovative products to restore mobility, function and performance.
Webcast
Meet The CEOs – 23 September
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to their industries...